Posted: 4 June 2025
La Trobe University has “switched on” Australia’s first AI-powered medical innovation centre with NVIDIA DGX H200 systems. This has marked a major step in AI-driven medical and biotech research.
Vice-Chancellor Professor Theo Farrell said, “AI is revolutionizing society at great speed, and La Trobe is dedicated to empowering our students and communities to adapt and thrive in this rapidly changing world.” He noted that the NVIDIA DGX H200 systems would enhance the speed and precision of scientific discoveries.
The NVIDIA DGX H200 supercomputer, the first at an Australian university, enables faster development of immunotherapies, cancer vaccines, and other medical technologies. It significantly reduces drug-development times, speeding up research translation into clinical trials and personalized therapies.
The Australian Centre for AI in Medical Innovation (ACAMI) at La Trobe serves as a training ground for scientists, clinicians, and data scientists. This initiative aims to build AI expertise crucial for rural and Indigenous health, biotech competitiveness, and digital health resilience. Professor Wei Xiang, ACAMI Director, highlighted AI’s transformative impact on drug development and precision medicine.
Supported by a $10 million investment from the Victorian Government through mRNA Victoria, the DGX H200 infrastructure and ACAMI became national hubs for AI-driven medical innovation. One of the first projects was a collaboration with The Florey Institute of Neuroscience and Mental Health on Niemann-Pick disease type C, a neurodegenerative disorder in children.
La Trobe University’s deployment of NVIDIA DGX H200 systems represents a bold step towards revolutionizing medical research and education, ensuring Australia remained at the forefront of AI innovation.
For more information, click here.
